ABCC1
protein-codingATP binding cassette subfamily C member 1, the group of ATP binding cassette subfamily C
Gene summary
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra-and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This full transporter is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a multispecific organic anion transporter, with oxidized glutatione, cysteinyl leukotrienes, and activated aflatoxin B1 as substrates. This protein also transports glucuronides and sulfate conjugates of steroid hormones and bile salts. Alternatively spliced variants of this gene have been described but their full-length nature is unknown. [provided by RefSeq, Apr 2012]
- MRP
- MRP1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~194.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: ClinGen
ABCC1 was first reported in relation to autosomal dominant nonsyndromic hearing loss in 2019 (Li et al., PMID: 31273342). 3 missense variants that have been reported in 3 probands in one publication (PMID: 31273342) are included in this curation. The variant segregated with disease in 10 members of one family. The affected individuals present with moderate to profound postlingual nonsyndromic hearing loss. The mechanism of pathogenicity is unclear. This gene-disease relationship is also supported by an expression study demonstrating ABCC1 localization on the stria vascularis as well as auditory nerves with a cytomembrane distribution (PMID: 31273342). Mouse models have also suggested a role for this gene in hearing loss, but relevant phenotypes were only observed following noise exposure (PMIDs: 38870779, 38951883). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Hearing Loss GCEP on the meeting date October 8, 2025 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0030058
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0030058
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ABCC1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004996.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 33 | 9 | 51 | ||
| missense | 1 | 165 | 18 | 5 | 189 | |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 11 | 11 | ||||
| Total | 1 | 0 | 186 | 51 | 14 | 252 |
Highest pathogenic variant AF is 0.000034073913
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004987.2 | 31 | MANE Select | |
| Ensembl | ENSP00000382342.3 | 31 | MANE Select | |
| RefSeq | NP_001425644.1 | 29 | Standard | |
| RefSeq | NP_001425646.1 | 28 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Methotrexate Pathway (Brain Cell), Pharmacokinetics
- Methotrexate Pathway, Pharmacokinetics
- Doxorubicin Pathway (Cancer Cell), Pharmacodynamics
- Vitamin digestion and absorption - Homo sapiens (human)
- ABC transporters - Homo sapiens (human)
Biological Process
- leukotriene metabolic process
- drug transmembrane transport
- cobalamin metabolic process
- cobalamin transport
- glutathione transmembrane transport
Molecular Function
- phospholipid-translocating ATPase activity
- transporter activity
- ATP binding
- xenobiotic transmembrane transporting ATPase activity
- cobalamin-transporting ATPase activity
Cellular Component
- vacuolar membrane
- plasma membrane
- integral component of plasma membrane
- membrane
- basolateral plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000399410
- Coding exons
- 31
- Length
- 193498
- Individuals with no LoFs
- 124854
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 56
- Defined
- 124910
- p
- 0.000224
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.77 | 782 | 935 | 0.837 | 0.0000594 | 9995 |
| Missense (PolyPhen) | 230 | 371.43 | 0.61923 | 3873 | ||
| Synonymous | -1.93 | 457 | 407 | 1.12 | 0.0000290 | 3053 |
| Loss of Function | 5.85 | 21 | 76.1 | 0.276 | 0.00000392 | 854 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00039 | 0.00038 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.000056 | 0.000056 | rare |
| Finnish | 0.00033 | 0.00032 | rare |
| European (Non-Finnish) | 0.00029 | 0.00029 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Mediates export of organic anions and drugs from the cytoplasm. Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o- glucuronide, methotrexate, antiviral drugs and other xenobiotics. Confers resistance to anticancer drugs. Hydrolyzes ATP with low efficiency. {ECO:0000269|PubMed:10064732, ECO:0000269|PubMed:11114332, ECO:0000269|PubMed:16230346}.;
Intolerance Scores
- LoFtool
- 0.0802
- RVIS EVS
- -0.84
- RVIS percentile EVS
- 11.29
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.291
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |